Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bushen Zhuanggu Oral Liquid (补肾壮骨口服液) is a traditional Chinese medicine (TCM) developed and manufactured by Guangdong Zhanjiang Jimin Pharmaceutical. Formulated as an oral liquid, it is indicated for 'kidney deficiency' and 'bone weakness' according to TCM principles, which typically correspond to conditions like osteoporosis or age-related skeletal degeneration. The medicine functions by tonifying the kidney and strengthening the bones. It is an approved product in China, marketed as part of the company's established portfolio of TCM treatments that includes various plasters and ointments.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Bushen Zhuanggu Oral Liquid.